Does EMTRICITABINE Cause Hepatocellular carcinoma? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hepatocellular carcinoma have been filed in association with EMTRICITABINE (Truvada). This represents 0.2% of all adverse event reports for EMTRICITABINE.
8
Reports of Hepatocellular carcinoma with EMTRICITABINE
0.2%
of all EMTRICITABINE reports
5
Deaths
0
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From EMTRICITABINE?
Of the 8 reports, 5 (62.5%) resulted in death.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMTRICITABINE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does EMTRICITABINE Cause?
Foetal exposure during pregnancy (609)
Drug resistance (370)
Virologic failure (331)
Immune reconstitution inflammatory syndrome (262)
Exposure during pregnancy (212)
Drug ineffective (196)
Pathogen resistance (166)
Viral mutation identified (161)
Maternal exposure during pregnancy (160)
Death (154)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which EMTRICITABINE Alternatives Have Lower Hepatocellular carcinoma Risk?
EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE
EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL
EMTRICITABINE vs EMTRICITABINE\TENOFOVIR
EMTRICITABINE vs EMTRICITABINE\TENOFOVIR ALAFENAMIDE
EMTRICITABINE vs EMTRICITABINE/TENOFOVIR DISOPROXIL